On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.
Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.
The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.
On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.
Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.
it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.
As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.
Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.
It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.
It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.
Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.
Credit: Canva
For the first time in 20 years, the US Food and Drug Administration (FDA) has added bemotrizinol to the list of permitted sunscreen active ingredients.
Bemotrizinol is the first new active ingredient added to the over-the-counter (OTC) sunscreen monograph since the late 1990s and has been used for years in Europe and Asia.
“As promised in the Trump Administration’s MAHA Strategy Report, HHS is advancing innovation by bringing a new sunscreen ingredient to the US market for the first time in 20 years,” said HHS Secretary Robert F. Kennedy Jr.
“Bemotrizinol has been used safely in Europe for decades, and FDA’s action will increase competition and consumer confidence in sunscreen products.”
On December 11, 2025, the FDA proposed allowing the use of bemotrizinol in sunscreens. The agency finalized the action within seven months of issuing the proposed order.
Bemotrizinol is known to provide stable, long-lasting protection against both types of ultraviolet (UV) rays that can damage the skin. According to the FDA, it is also gentle enough to be used safely by young children.
Also read: X-Men Star Tyler Mane Reveals ‘Super-Rare’ Male Breast Cancer Diagnosis
Bemotrizinol, also known as BEMT, is a chemical sunscreen filter that absorbs both UVB and UVA rays. The sun emits ultraviolet radiation, which sunscreen products are designed to block.
UVA and UVB rays affect the skin differently. UVA rays are primarily associated with tanning and skin ageing, while UVB rays are more closely linked to sunburn. UVB rays can also be partially blocked by barriers such as windows and clouds.
According to the University of Texas MD Anderson Cancer Center, about 95 per cent of the UV radiation reaching the Earth's surface is UVA, while UVB accounts for the remaining 5 per cent.
Sunscreens protect the skin either by creating a physical barrier using mineral ingredients or by using chemical filters that absorb UV radiation before it reaches the skin. Bemotrizinol belongs to the latter category.
The addition of BEMT is being welcomed by many experts because options that are both highly effective and considered safe remain limited in the US sunscreen market, according to an annual report by the Environmental Working Group (EWG), a nonprofit health and environmental advocacy organization.
Read More: Confused By Your Cholesterol Report? Here's What LDL And ApoB Really Mean
Bemotrizinol offers several characteristics that make it an effective sunscreen ingredient. It provides broad-spectrum protection against both UVA and UVB radiation and can achieve higher SPF protection at lower concentrations than some other commonly used sunscreen chemicals, according to Certified Laboratories and the FDA.
The ingredient is also photostable, meaning it breaks down more slowly when exposed to sunlight, helping maintain protection for longer periods. Because it is oil-soluble, it can be easily incorporated into creams and lotions.
In addition, bemotrizinol is minimally absorbed through the skin and rarely causes irritation, which is one reason the FDA considers it safe for use in children as young as six months old.
Meanwhile, DSM Nutritional Products, a manufacturer submitted an OTC monograph order request seeking to add bemotrizinol, marketed as Parsol Shield, at concentrations of up to 6 per cent as a new active ingredient in the OTC sunscreen monograph.
“The FDA reviewed the request and proposed to amend the OTC monograph to add bemotrizinol as a sunscreen active ingredient,” the agency said in its announcement.
In December 2025, DSM had announced that, once approved, Parsol Shield would be available for use in sunscreen products in accordance with the monograph requirements.
According to the FDA, OTC monograph drugs such as sunscreens can enter the market without an approved drug application if they meet specific requirements, including permitted active ingredients, uses and dosage limits established under the monograph.
The FDA can modify an OTC monograph through an administrative order, and manufacturers can initiate the process by submitting an OTC monograph order request.
Raghu Ram took to Instagram to share anecdotes from his journey. (Photo credit: AI generated)
Remember Raghu Ram from the MTV reality show 'Roadies'? The actor and television host recently celebrated 10 years of a smoke-free life and took to Instagram to share his progress with fans. Smoking is injurious to health, and that is a known fact. It is associated with heart disease, cancer, hypertension, and even respiratory difficulties in the future. This habit can turn fatal too if one becomes addicted to nicotine. But for Raghu Ram, this journey ended 10 years ago, and he has never looked back since.
"Iss mahine cigarette chhodkar mujhe pure 10 saal ho gaye hain. Or main aisa waise smoker nhi tha. Main peeta tha din mein 1-2 packets daily. Yani 20-40 cigarettes roz. Par maine bahut koshish ki chhodne ki, lekin addiction hoti hai, chor nhin pate hain log. Main bhi nhin chor paya tha," Raghu said in an Instagram video.
"Aisa chora ki wapas ek bhi kash nahin mara. 10 saal ho gaye hain mereko," he added.
On his podcast Mencyclopedia in 2023, Raghu Ram revealed that he once smoked 20–40 cigarettes a day for 15 years and then suddenly stopped.
"I smoked 20–40 cigarettes every day for 15 years, and then I just stopped. Cold turkey. And I had not taken a puff of a cigarette in 7 years," he said in his podcast titled How I Won the Longest Battle with My Addiction.
After trying several times to quit, Raghu Ram finally gave up smoking after marrying his wife, Natalie Di Luccio, a Canadian singer, in 2018.
Here is a simple seven-step guide from the former 'Roadies' host and judge:
For every person who has ever quit smoking or wanted to do it
For everyone who has ever quit smoking, the reasons may look different, but they all have two things in common: first, an addiction they are battling; and second, withdrawal symptoms to overcome. You may not be able to follow Raghu Ram's seven-step guide exactly, but his story is inspiring enough to encourage people to try quitting smoking.
Credit: Tyler Mane/ Instagram
X-Men actor Tyler Mane has revealed that he has been diagnosed with a "super-rare" form of breast cancer.
In a post on Instagram, Mane, a former professional wrestler, shared that he has been diagnosed with the condition, which is predominantly associated with women. He noted that only about 1 per cent of breast cancer cases occur in men.
The 59-year-old actor said he initially considered keeping his diagnosis private, but ultimately decided to speak publicly about it because men are often diagnosed at more advanced stages of the disease due to a lack of awareness.
“I have some bad news: I start chemo today. One in 750 men will be diagnosed with breast cancer in their lifetime and I’m one of them,” he said in a video posted on Instagram.
Mane revealed that doctors initially dismissed the lump he discovered.
“My doctors initially dismissed it and it was only because my wife pushed me to get the lump removed that I got in early,” he said.
The actor admitted that his first instinct was to keep the diagnosis secret.
“I’ll be honest, my first reaction was to keep it secret. I mean it’s kind of embarrassing,” he said.
However, after learning more about male breast cancer and the importance of early detection, he decided to share his experience publicly to help raise awareness.
While Mane did not reveal the stage of his cancer, he informed of undergoing chemotherapy and urged his followers to spread awareness about the disease.
“I’m gonna kick cancer’s ass. Thank you for coming along for the journey. We need to spread the awareness. Cancer sucks but if you catch it quick enough, you can win this battle,” he wrote.
According to the CDC, about one in every 100 breast cancer cases diagnosed in the United States occurs in men. The situation is similar globally, with the World Health Organization estimating that between 0.5 and 1 per cent of breast cancers occur in men.
The lifetime risk of breast cancer in men is currently less than one in 1,000. However, the incidence of the disease is increasing, particularly with advancing age.
The average age at diagnosis for men is about 67 years, roughly five years later than the average age of diagnosis in women.
Because breast cancer is often not suspected in men, the condition can be overlooked or misdiagnosed, resulting in many cases being detected at later stages.
Several factors can increase a man's likelihood of developing breast cancer. These include:
The symptoms of breast cancer in men are similar to those in women, but men may overlook them because they are less aware of the disease.
Common signs include:
Routine mammography is not generally recommended for men because of the low prevalence of the disease. However, men considered to be at high risk, including those with a strong family history or genetic predisposition, may benefit from periodic screening and should discuss appropriate options with their healthcare providers.
© 2024 Bennett, Coleman & Company Limited